Fluralaner Market Size, Share, Growth, and Industry Analysis, By Type (Purity ≥ 98% and Purity ≥ 99%), By Application (Oral Drug and Topical Drug), Regional Insights and Forecast From 2025 To 2033

• 

   Request a Free Sample To Get More Information on this Market

FLURALANER MARKET REPORT OVERVIEW

Global fluralaner market size was estimated at USD 0.03 billion in 2024 and is expected to reach USD 0.05 billion by 2033 at a 8.7% CAGR during the forecast period.

Fluralaner is a broad-spectrum systemic insecticide and acaricide that belongs to the isoxazoline class. It is commonly used for the treatment and prevention of flea and tick infestations in dogs and cats. Fluralaner works by inhibiting the GABA and glutamate-gated chloride channels in the nervous system of parasites, leading to the paralysis and death of the targeted pests. It is known for its long-lasting efficacy, typically providing protection against fleas for up to 12 weeks and against ticks for up to 12 weeks in dogs, depending on the specific product formulation and dosage. For cats, it provides protection against fleas for up to 12 weeks and against ticks for up to 8 weeks.

The most common form of fluralaner administration is through flavored chewable tablets, making it easier for pet owners to administer the treatment to their pets. These chewable tablets are palatable and are generally well-tolerated by dogs and cats, ensuring convenient and effective parasite control.

COVID-19 IMPACT

"Supply Chain Disruptions to Hamper Demand Significantly"

The COVID-19 pandemic has been unprecedented and staggering, with fluralaner experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

COVID-19 had a life changing impact globally. Thefluralaner market growth was significantly affected. The virus had various impacts on different markets. Lockdowns were imposed in several nations. This erratic pandemic caused disruptions on all sorts of businesses. Restrictions tightened during the pandemic due to increasing number of cases. Numerous Industries were affected. However, the market for fluralaner share experienced a reduced demand.

The pandemic led to disruptions in global supply chains, affecting the production and distribution of various products, including fluralaner-based treatments. Disruptions in the supply chain, particularly in the manufacturing and transportation of goods, led to shortages and delays in product availability. With lockdowns and restrictions in place, there may have been shifts in the distribution channels for pet care products, including fluralaner. Increased reliance on e-commerce platforms for pet supplies and treatments may have altered the traditional distribution landscape, influencing the accessibility and availability of fluralaner products.

During the height of the pandemic, many pet owners postponed non-essential veterinary visits and treatments, leading to a decline in routine check-ups and preventive care, including flea and tick treatments. This reduction in veterinary visits may have impacted the overall demand for fluralaner-based products. The market is anticipated to boost the fluralaner market growth following the pandemic.

LATEST TRENDS

"Advanced formulations to Broaden Market Growth"

Manufacturers are likely to focus on developing advanced formulations of fluralaner-based products, including spot-on treatments, collars, and sprays, to cater to the diverse preferences of pet owners and provide more convenient administration options. There might be a growing emphasis on developing fluralaner products that offer extended protection against fleas and ticks, potentially with longer efficacy periods than the traditional formulations, providing pet owners with added convenience and peace of mind.

With an increasing focus on pet safety and wellness, manufacturers may prioritize the development of fluralaner formulations that have minimal side effects and are well-tolerated by pets, ensuring the overall health and comfort of animals receiving treatment. These latest developments are anticipated to boost the fluralaner market share.

FLURALANER MARKET SEGMENTATION

By Type

Based on type, the market is divided into Purity ≥ 98% and Purity ≥ 99%.

By Application

Based on application, the market is bifurcated into Oral Drug and Topical Drug.

DRIVING FACTORS

"Rising Awareness of Pet Health to Boost Market Share"

The growing global pet population, particularly dogs and cats, has led to an increased demand for effective and reliable parasite control solutions, driving the growth of the fluralaner market. Pet owners are becoming increasingly aware of the health risks associated with flea and tick infestations in pets. This heightened awareness has led to a greater emphasis on preventive care, including the use of fluralaner-based products, to ensure the overall health and well-being of their pets. Recommendations from veterinary professionals play a crucial role in influencing the purchasing decisions of pet owners. Vets often recommend fluralaner-based products for their proven efficacy and safety in controlling parasites, further driving the growth of the market.

"Product Innovation & Development to Boost Market Growth"

Fluralaner is known for its high efficacy in controlling fleas and ticks, providing long-lasting protection for pets. Its ability to provide extended protection from infestations has contributed significantly to its growing demand in the market. Manufacturers are continuously focusing on research and development activities to introduce advanced formulations and delivery methods for fluralaner-based products. Ongoing product innovations, such as new application methods and longer-lasting formulations, contribute to the expansion of the market. . These factors are anticipated to drive the fluralaner market share.

RESTRAINING FACTORS

"Competition from Alternative Products to Hamper Market Share"

Fluralaner-based products, known for their high efficacy and long-lasting protection, may come at a premium price point compared to some alternative treatments. Price sensitivity among some pet owners and the availability of lower-cost alternatives can impact the adoption and market penetration of fluralaner products. The fluralaner market faces competition from various alternative products such as topical treatments, collars, and sprays for flea and tick control. Competitive pricing and varying efficacy levels of these alternatives can impact the market share of fluralaner-based products. The factors are anticipated to hinder the growth of the fluralaner market growth.

• 

   Request a Free Sample To Get Analysis on Major Geographic Market

FLURALANER MARKET REGIONAL INSIGHTS

"North America Dominates the Fluralaner Market "

North America, particularly the United States and Canada, is often a major shareholder in the global fluralaner market. The region has a substantial pet population, and pet owners often prioritize preventive care and advanced treatments for their pets, contributing to the demand for effective parasite control solutions like fluralaner. Additionally, the presence of well-established veterinary care services and a strong focus on pet health and wellness further boosts the market share in this region.

KEY INDUSTRY PLAYERS

"Key Players Focus on Partnerships to Gain a Competitive Advantage "

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead in the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolio.

List of Top Fluralaner Companies

• Nissan Chemical Corporation [Japan]
• Rivocean Jiangsu Pharmaceutical Co., Ltd. [China]
• Dideu Group [China]
• Hikal Ltd. [India]
• Masteam Bio-tech (Wuhan) Co., Ltd. [China]

REPORT COVERAGE

This research profiles a report with extensive studies that take into description of the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc. This analysis is subject to alteration if the key players and probable analysis of market dynamics changes.